MANAGEMENT TEAM

Ted Daley, Co-founder & CEO

Mr. Daley was previously President and Chief Business Officer for Raptor Pharmaceuticals. He joined Raptor through its acquisition of Convivia, Inc., which he founded. He also co-founded and was Chief Operating Officer for Instill Corporation, a pioneering e-commerce company. Mr. Daley has advised and consulted for numerous technology and life science start-ups.

Felix Frueh, PhD, Co-founder & CSO

Dr. Frueh was previously CSO at Human Longevity, Inc. He was the President of the Medco Research Institute and the first Associate Director for Genomics at FDA. In addition, he held executive positions in multiple biotechnology companies and serves on the Boards of several biotechnology corporations and non-profit organizations. Dr. Frueh is a Fellow of the American College of Clinical Pharmacology and held faculty positions at Georgetown University in Washington, DC and at the University of North Carolina.

Ken Krantz, MD, PhD, CMO

Dr. Krantz has more than forty years of industry experience, including executive research management positions at large and small companies, and successful experience with clinical programs and regulatory authorities. Dr. Krantz has participated in or directed 30 INDA and 17 NDA/BLA/ANDA submissions.

Dan Maneval, PhD, Head of Preclinical and Bioanalytical

Dr. Maneval is a scientific leader/executive with 25+ years of experience in preclinical development of novel biotherapeutics. He has held leadership roles in small/emerging biotechnology companies as well as large biopharmaceutical organizations and provides consulting advice to start-up and virtual companies.

Julia Ortega, PA, MHS, Head of Clinical Operations

Ms. Ortega is a clinical research executive with 30 years of clinical operations and regulatory experience in Phase 1 – 4 studies. Additionally she has 20 years of patient care experience as a Physician Assistant, which she incorporates into her work with clinicians, patients, and sites. She has held leadership roles with biotech companies as well as health payers to include multiple start-up organizations.

Kathy Powell, MS, Head of CMC

Ms. Powell has held leadership positions in biopharmaceutical product development and quality functions for over 20 years, both as a consultant and in management roles at companies including Genentech and Raptor Pharmaceuticals.

BOARD OF DIRECTORS

Kenneth J. Kelley, MBA, Chairman

Mr. Kelley is assisting Selva with funding and corporate development. He was a White House Presidential Executive Fellow, Advisor to the Biomedical Advanced Research and Development Authority (BARDA) and to the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID) on emerging infectious disease threats. Mr. Kelley is co-founder and/or director on the Boards at Adjuvance Technologies, SeromYx Systems, Meissa Vaccines, ID Biologics, and Public Health Vaccines, LLC. He also was the Founder and CEO of PaxVax.

Ted Daley, Co-founder & CEO

Mr. Daley was previously President and Chief Business Officer for Raptor Pharmaceuticals. He joined Raptor through its acquisition of Convivia, Inc., which he founded. He also co-founded and was Chief Operating Officer for Instill Corporation, a pioneering e-commerce company. Mr. Daley has advised and consulted for numerous technology and life science start-ups.

Felix Frueh, PhD, Co-founder & CSO

Dr. Frueh was previously CSO at Human Longevity, Inc. He was the President of the Medco Research Institute and the first Associate Director for Genomics at FDA. In addition, he held executive positions in multiple biotechnology companies and serves on the Boards of several biotechnology corporations and non-profit organizations. Dr. Frueh is a Fellow of the American College of Clinical Pharmacology and held faculty positions at Georgetown University in Washington, DC and at the University of North Carolina.

ADVISORS

James McKerrow, MD, PhD, Scientific Advisor

Dr. McKerrow is the Dean of Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego Health Sciences. Prior, he served as Professor of Pathology and Director of the Center for Discovery and Innovation in Parasitic Diseases, UC San Francisco. Dr. McKerrow founded and served as chief executive officer of Demeter Pharmaceuticals, a non-profit company focusing on acquisition and screening of the largest marine natural products library in the United States. He is a member of the American Society for Cell Biology, American Society of Microbiology, American Society of Biochemistry and Molecular Biology, American Society of Tropical Medicine and Hygiene, American Society of Parasitologists and the American Society of Immunologists.

Sheba Meymandi, MD, Scientific Advisor

Dr. Sheba K. Meymandi is the director of the Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, which opened in 2007 as the first U.S. clinic for the diagnosis and treatment of Chagas disease. Dr. Meymandi is a Clinical Professor of Medicine at UCLA’s David Geffen School of Medicine, the Associate Medical Director of Olive View-UCLA Medical Center and the Director of Cardiovascular Research and Invasive Cardiology at Olive View-UCLA Medical Center.